MEDIFAST INC (MED) Financials
MED Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 309.9 million | 108.4 million |
| 2023-09-30 | 320.0 million | 127.0 million |
| 2023-06-30 | 318.7 million | 133.2 million |
| 2023-03-31 | 321.6 million | 150.7 million |
MED Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 9.6 million | 2.4 million |
| 2023-09-30 | 28.3 million | 2.7 million |
| 2023-06-30 | 41.4 million | 2.5 million |
| 2023-03-31 | 61.9 million | 606000 |
MED Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 6.0 million |
| 2023-09-30 | 23.1 million |
| 2023-06-30 | 30.3 million |
| 2023-03-31 | 40.0 million |
MED Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 150.0 million | - | 22.0 million |
| 2023-09-30 | 157.8 million | - | 22.3 million |
| 2023-06-30 | 147.4 million | - | 23.7 million |
| 2023-03-31 | 123.7 million | - | 24.4 million |
MED Shares Outstanding
MED Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 946000 | 1.2 million | 132.7 million | - |
| 2023-09-30 | 1.7 million | 1.3 million | 150.6 million | - |
| 2023-06-30 | 1.7 million | 1.1 million | 172.0 million | - |
| 2023-03-31 | 2.1 million | 1.0 million | 192.9 million | - |
MED Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 191.0 million | 49.6 million |
| 2023-09-30 | 235.9 million | 58.5 million |
| 2023-06-30 | 296.2 million | 85.5 million |
| 2023-03-31 | 349.0 million | 102.6 million |
MED
List: Challengers
Price: $32.44
Dividend Yield: 0.16%
Forward Dividend Yield: 10.17%
Payout Ratio: 60.11%
Dividend Per Share: 3.30 USD
Earnings Per Share: 9.10 USD
P/E Ratio: 4.69
Exchange: NYQ
Sector: Consumer Cyclical
Industry: Personal Services
Volume: 214177
Ebitda: 11.3 millionMarket Capitalization: 348.1 million
Average Dividend Frequency: 3
Years Paying Dividends: 9
DGR3: 11.48%
DGR5: 20.81%